Navigation Links
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
Date:5/9/2008

ghts of suicide or sudden changes in mood or behavior, especially at the beginning of treatment or after a change in dose.

Strattera should not be taken if you or your child: are taking or have taken within the past two weeks a medicine for depression called a monoamine oxidase inhibitor (MAOI); have an eye problem called glaucoma; are allergic to anything in STRATTERA.

Tell your doctor if you or a family member has a history of high or low blood pressure, increased heart rate, heart or blood vessel disease or structural heart defects. When on Strattera, tell your doctor right away if you have chest pain, shortness of breath, or fainting, as these may be signs of heart-related conditions that may be life threatening.

In rare cases, Strattera can cause severe liver problems. Call your doctor right away if you or your child has itching, dark urine, yellow skin/eyes, upper right-side abdominal tenderness, or unexplained "flu-like" symptoms.

Tell the doctor about any family history of or if you or your child: has bipolar illness (manic-depressive illness); or has suicidal thoughts or actions before starting Strattera.

If your child develops new psychological symptoms such as abnormal thoughts/behaviors and/or extreme elevated or irritable moods, while taking Strattera you should report them to your child's doctor right away.

For male patients, call your doctor right away if you or your child experience priapism, a painful or prolonged erection lasting more than 4 hours.

Other rare but serious side effects include: serious allergic reactions including swelling, hives, or other allergic reactions; problems passing urine; and slowing of growth in children. As with all ADHD medications, growth should be monitored during treatment although height and weight data for Strattera measured up to 3 years indicates minimal, if any, long-term effects.

Tell your doctor about all prescription and nonprescription medicines that yo
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... N.C. (PRWEB) October 30, 2014 Paramount ... health care, is increasing efforts to help people save ... expenses continue to increase for prescription drugs in the ... valuable savings and resources to bridge the relationship between ... One of the biggest challenges people face today with ...
(Date:10/30/2014)... By Dennis Thompson ... -- The Ebola outbreak in Liberia -- one of three ... slowing, World Health Organization officials said Wednesday. Dr. Bruce ... in the number of burials in Liberia and no increase ... the global push to tame the epidemic may be making ...
(Date:10/30/2014)... California (PRWEB) October 30, 2014 Global ... by 2020, according to a new study by Grand ... with surging demand for sugar and fat free products ... augment the demand for prebiotics over the forecast period. ... http://www.grandviewresearch.com/industry-analysis/prebiotics-market , Food & beverage was the largest ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The annual ... (NAMS) came to a close on Saturday, October 18th, ... the Society’s inception in 1989. NAMS is North America’s ... quality of life of all women during midlife and ... With over 2,000 physicians and thought leaders from fields ...
(Date:10/30/2014)... Scientists who used stem cells to create miniature human ... a new way to learn more about the development ... human pluripotent stem cells -- which can become any ... the functional miniature stomachs, to study infection by ... and stomach cancer. The miniature stomachs offer many ...
Breaking Medicine News(10 mins):Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3
... of barrier islands published earlier this spring offers the most ... that hug the coasts of the world,s landmasses. The study, ... Orrin Pilkey of Duke University, Durham, N.C., offers new insight ... and how they may fare as the climate changes and ...
... a small, observational study conducted at the University at ... treat type 2 diabetes, also helps type 1 diabetics ... levels. If the findings are confirmed in a ... UB researchers, they could mean the first significant, new ...
... a new study published today in the journal Nature ... genetic code. The findings, though early, are significant because they ... disorders, such as cystic fibrosis, muscular dystrophy and many forms ... of instructions in a gene that tell a cell how ...
... WEDNESDAY, June 15 (HealthDay News) -- A full 80 percent ... of life expectancy, and the gap is getting bigger, according ... areas of the United States is actually decreasing, whereas it,s ... "The gap between the U.S. and the 10 countries ...
... & Africa Osteoporosis Meeting, to be held in Dubai, ... at , http://www.iofbonehealth.org/dubai-2011/programme.html To encourage participation ... USD each for the top five abstracts by investigators ... is June 17, 2011; all accepted abstracts will be ...
... (June 15, 2011) Geisinger Health System vaccinated more ... with a modification of a mandatory program. On ... flu vaccinations. In an article published in July,s ... of the Society for Healthcare Epidemiology of America, Dr. ...
Cached Medicine News:Health News:What will climate change and sea level rise mean for barrier islands? 2Health News:What will climate change and sea level rise mean for barrier islands? 3Health News:What will climate change and sea level rise mean for barrier islands? 4Health News:Study suggests drug significantly improves glycemic control in type 1 diabetics on insulin 2Health News:Changing genetic 'red light' to green holds promise for treating disease 2Health News:Changing genetic 'red light' to green holds promise for treating disease 3Health News:U.S. Found to Be Losing Ground in Life Expectancy 2Health News:U.S. Found to Be Losing Ground in Life Expectancy 3Health News:Program announced for 1st Middle-East & Africa Osteoporosis Meeting 2Health News:Health system achieves high flu vaccination rates by mandating masking 2
(Date:10/30/2014)... 2014 CVS Health (NYSE: CVS ) ... three leading regional health systems to enhance access to high-quality, ... include Baptist Health System in Alabama ; ... in Pennsylvania , Northwest Medical Center, including ... Tennova Healthcare in Tennessee ; and Premier ...
(Date:10/30/2014)... , Oct. 30, 2014  CytRx Corporation ... and development company specializing in oncology, today announced ... its lead drug candidate, aldoxorubicin.  The presentation, titled, ... Approach," will be given by Sant P. ... Oncology Center and principal investigator of the Company,s ...
(Date:10/30/2014)... Oct. 30, 2014 Today, DripDrop, the ... that it was awarded a two-year contract, effective ... company that serves the more than 100,000 members ... Association and Provista.  DripDrop also ... from member hospitals who attended the recent Novation ...
Breaking Medicine Technology:CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 2DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 3DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 4
... Reportlinker.com announces that a new market research ... Vaccines - Western Europe ... market research report package offers an in-depth perspective ... outlook for vaccines in Western European markets. The ...
... 2012 Reportlinker.com announces that a new ... catalogue: Pharmaceuticals: Global ... http://www.reportlinker.com/p0191852/Pharmaceuticals-Global-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu Pharmaceuticals: Global Industry ... data and analysis covering the Pharmaceuticals industry. ...
Cached Medicine Technology:Vaccines - Western Europe 2Pharmaceuticals: Global Industry Guide 2Pharmaceuticals: Global Industry Guide 3Pharmaceuticals: Global Industry Guide 4Pharmaceuticals: Global Industry Guide 5Pharmaceuticals: Global Industry Guide 6Pharmaceuticals: Global Industry Guide 7Pharmaceuticals: Global Industry Guide 8Pharmaceuticals: Global Industry Guide 9Pharmaceuticals: Global Industry Guide 10Pharmaceuticals: Global Industry Guide 11Pharmaceuticals: Global Industry Guide 12Pharmaceuticals: Global Industry Guide 13Pharmaceuticals: Global Industry Guide 14Pharmaceuticals: Global Industry Guide 15
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
... The InstaCheck® multi-drug test ... simply and easily. Negative results ... few as 3 minutes; positive ... A simple, one-time urine sample ...
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
AccuSign® DOA Series Opiates Test...
Medicine Products: